KBLB - Kraig Biocraft Laboratories, Inc.

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-3,842
-3,842
-8,046
-4,971
-2,910
Depreciation & amortisation
28.103
28.103
26.137
28.074
30.781
Change in working capital
499.635
499.635
618.485
733.71
1,092
Accounts receivable
-
-
-
-
0
Inventory
-6.58
-6.58
-
-
-
Accounts payable
138.159
138.159
199.723
39.055
314.369
Other working capital
-1,892
-1,892
-1,898
-1,255
-1,189
Other non-cash items
1,192
1,192
5,041
109.322
22.337
Net cash provided by operating activities
-1,887
-1,887
-1,801
-1,255
-1,088
Cash flows from investing activities
Investments in property, plant and equipment
-5.021
-5.021
-97.154
-
-100.792
Purchases of investments
0
0
-450.216
-
-
Net cash used for investing activities
-100.792
-5.021
-547.37
-
-100.792
Cash flows from financing activities
Debt repayment
-100
-100
-50
-40
-20
Common stock issued
-
-
0
17.495
1,000
Other financing activities
-
-
-
-86
-
Net cash used provided by (used for) financing activities
3,400
3,400
3,886
1,947
1,300
Net change in cash
1,508
1,508
1,538
691.883
111.327
Cash at beginning of period
2,355
2,355
816.907
125.024
13.697
Cash at end of period
3,863
3,863
2,355
816.907
125.024
Free cash flow
Operating cash flow
-1,887
-1,887
-1,801
-1,255
-1,088
Capital expenditure
-5.021
-5.021
-97.154
-
-100.792
Free cash flow
-1,892
-1,892
-1,898
-1,255
-1,189